JNEMX Mutual Fund

NAV$24.73

Fund Essentials - as of Jan 31, 2026

Net Assets
$4.0B
Expense Ratio
0.50%
Dividend Yield (Current)
6.11%
Holdings
92
Inception Date
Nov 30, 2010
Fund Family
J.P. Morgan Asset Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+8.69%
1 Year+15.11%
3 Year+13.75%
5 Year+7.00%
10 Year+9.41%

Asset Allocation

Stocks: 98.65%
Cash: 1.34%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ASML:ASAsml Holding Nv3.86%
SAF:PASafran Sa2.55%
DBSM:SIDbs Group Holdings Ltd2.51%
AZN:LNAstrazeneca Plc Adr2.49%
8306:JPMitsubishi UFJ Financial Group Inc.2.26%
Top 10 Concentration: 24.49%Report Date: Jan 31, 2026
Download all 92 holdings for JNEMX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.11%
Frequency
Annually
Latest Distribution
$0.46
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how JNEMX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

JNEMX Mutual Fund Overview

JNEMX Mutual Fund (JPMorgan International Equity Fund Class R6) is managed by J.P. Morgan Asset Management with $3.99B in net assets. JNEMX expense ratio is 0.50%, holding 92 positions across sectors including Unknown, Financials, Industrials. Inception date: 2010-11-30.

JNEMX performance shows a YTD return of 8.69%. The 1-year return is 15.11% and the 5-year return is 7.00%. JNEMX dividend yield stands at 6.11%, paid annually.

JNEMX top holdings include Asml Holding Nv (3.9%), Safran Sa (2.5%), Dbs Group Holdings Ltd (2.5%), Astrazeneca Plc Adr (2.5%), Mitsubishi UFJ Financial Group Inc. (2.3%). View all JNEMX holdings, sector breakdown, or dividend history.

JNEMX can be compared against other funds using the overlap calculator or side-by-side comparison tool. JNEMX alternatives are available via the screener, along with tax-loss harvesting opportunities.